Bio-Medical Applications Management Company Inc Concord, NC - 28025

Bio-Medical Applications Management Company Inc is categorized under Kidney Dialysis Centers in Concord, NC .

Bio-Medical Applications Management Company Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 621492 by the NAICS.

If you are seeking more information, feel free to contact Sandy Dorton at the company’s branch by writing to 217 Branchview Drive Se, Concord, North Carolina NC 28025 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Bio-Medical Applications Management Company Inc
Contact Person: Sandy Dorton
Address: 217 Branchview Drive Se, Concord, North Carolina 28025
Annual Revenue (USD): Unknown
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Kidney Dialysis Centers
SIC Code: 8092
NAICS Code: 621492
Share This Business:

Bio-Medical Applications Management Company Inc was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 621492. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Sandy Dorton for inquiries that concern Bio-Medical Applications Management Company Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the branch of Bio-Medical Applications Management Company Inc can be found at the coordinates 35.413496,-80.569518 as well as the street address 217 Branchview Drive Se in Concord, North Carolina 28025.

For its online presence, you may visit Bio-Medical Applications Management Company Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.